Cosmetic Surgery Times e-News:

Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Subscribe Now

to Cosmetic Surgery Times e-News
Cosmetic Surgery Times
Part of the Modern Medicine Network

e-News

CosmeticSurgeryTimes.com

June 30, 2011
Cosmetic Surgery Times
Resource Centers Information Technology Practice Management Meeting Calendar
Hot Topics
Maximize goodwill
when selling practice
Be prepared to provide
records sought in lawsuit
Retired surgeon shifts
to offering primary care

FYI ...

9%

The percentage of decline in microdermabrasion procedures from 2009
to 2010

Source: American Society
of Plastic Surgeons

Connect to Us

Twitter Follow Us on Twitter

Digital Edition
Cosmetic Surgery Times Digital Edition View Current Edition Subscribe to the Digital Edition

FDA OKs autologous cell therapy

Exton, Pa. — Fibrocell Science has won Food and Drug Administration (FDA) approval for an injectable wrinkle treatment that uses a patient's own cells, Bloomberg.com reports. Read full article.

 Sample article image
divider

Confirm your e-newsletter subscription click here.

To ensure future delivery of email newsletters from Cosmetic Surgery Times please take a moment to confirm your subscription by clicking here.
Thank you,
Cosmetic Surgery Times Staff

divider

Silicone implants won't last forever

Boston — Silicone breast implants probably will not last forever, and may need to be removed or replaced within a decade of implantation, according to a report released last week by the Food and Drug Administration (FDA). Read full article.

divider

Dysport tops Botox for crow's feet

San Francisco — Crow's feet respond significantly better to treatment with Dysport (abobotulinumtoxinA, Medicis) than to treatment with Botox (onabotulinumtoxinA, Allergan), according to results of what is reportedly the first randomized trial comparing the two. Read full article.

divider

Immediate reconstruction risk low

Los Angeles — Immediate breast reconstruction following mastectomy has a low risk of complications and does not unduly delay cancer treatment, a new study finds. Read full article.

divider

Career Opportunities

Birmingham Cosmetic Surgery Culver City Surgical Center
Premiere Center for Cosmetic Surgery Steve Orten, MD

Contact Us

Contact a Cosmetic Surgery Times editor Click Here
Contact a Cosmetic Surgery Times sales representative Click Here
Learn about direct mail, reprints and classifieds in Cosmetic Surgery Times Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Medical Communications Group

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.